Abstract:Objective: With the proposal of penumbra theory and development of intra-arterial thrombolysis (such as urokinase), the outcome of ischemic cerebrovascular disease is greatly improved. However, the incidence of hemorrhagic transformation (HT) increased concomitantly, and some studies showed a close relationship between blood pressure and HT. The mechanisms of blood pressure and urokinase effect on the incidence of HT are not clear. In this study, we investigated the effects of the different levels of blood pressure and urokinase on the ischemic lesions, the incidence of HT and the expression of matrix metalloproteinase 9 (MMP-9) in the rat ischemia-reperfusion models. Methods: Temporary focal ischemia was induced in male Sprague-Dawley rats using the intraluminal vascular occlusion method. The animals were assigned into four groups (n=11 in each group): low blood pressure group (LP), normal blood pressure group (NP), high blood pressure group (HP) and urokinase/high blood pressure group (UKHP). Adnephrin was applied to enhance the mean arterial blood pressure (MABP) at the beginning of reperfusion. MABP was maintained 20 mmHg higher than the baseline for 1 hour. Sodium nitroprusside was used to decrease MABP by 20 mmHg lower than the baseline for 1 hour. Both urokinase and adnephrin were used concomitantly in the UKHP group. Neurological deficit scores were evaluated at 2 hours (R2h) and 24 hours (R24h) after reperfusion. All rats were decapitated, their brains were sliced into 15-mu m-thick slices, and the infarct volume and the visible HT were analysed. Three rats in each group were taken for immunohistochemistry and pathological analysis. Results: There was no significant difference in MABP among the groups at the baseline time points (p>0.05), but blood pressure are definitely increased and decreased in the HP, UKHP, and LP groups. Neurological deficit scores showed no significant difference at R2h among the groups (p=0.443). However, neurological deficit scores showed significant differences at R24h among the groups, the neurological deficits scores of rats in the LP group are significantly higher than that in the other groups. Compared with that of 2 hours after reperfusion, neurological deficit scores deteriorated in the LP group (p=0.047) but was improved in the NP, HP and UKHP groups (p=0.076, 0.002, 0.017, respectively) at 24 hours after reperfusion. The infarct volume in the HP group was apparently smaller than that in the LP group (p=0.006). There was indeed a tendency that HT occurred more frequently in the UKHP group (42.8%) than in the HP (25%) and LP (28.5%) groups. MMP-9 expression showed significant increase around the ischemic lesion areas of the UKHP group and significant decrease in the cortical areas of the LP and HP groups but no significant difference in the basal ganglia of rats of all groups. Conclusion: Mild elevation of blood pressure during reperfusion is supposed to improve neurological outcomes in rats following ischemia/reperfusion. The incidence of HT tended to increase with the elevation of blood pressure and the administration of urokinase. Immunohistochemitry analysis indicated that incidence of HT may correlate with excessive expression of MMP-9. [Neurol Res 2009; 31: 204-208]

Effects of ulinastatin on delayed cerebral vasospasm following subarachnoid hemorrahage in rats and its neuroprotection

Effects of Ulinastatin on Renal Ischemia-Reperfusion Injury in Rats

Effect of Ulinastatin on Neuron Apoptosis and CCAAT/enhancer-binding Protein Expression of Spinal Cord after Peripheral Nerve Injury

Protection Effects of Ulinastatin Against Lung Warm Ischemia-Reperfusion Injury in Rats

The effects of blood pressure and urokinase on brain injuries after experimental cerebral infarction in rats.

Neuroprotective effect and mechanism of hydrogen-rich saline against subarachnoid hemorrhage in rats

Effect of Ulinastatin on the Permeability of the Blood-Brain Barrier on Rats with Global Cerebral Ischemia/reperfusion Injury As Assessed by MRI.

Effects of Ulinastatin on Global Ischemia Via Brain Pro-Inflammation Signal.

Neuroprotection effect of minocycline on early brain injury after subarachnoid hemorrhage in rats

Neuroprotection of Ulinastatin on Transient Cerebral Ischemia Via Antioxidative Mechanisms.

Effect of Fasudil Hydrochloride on Cerebral Vasospasm Following Experimental Subarachnoid Hemorrhage

The Protective Effect of Cardamonin on the Factors Involved in Delayed Cerebral Vasospasm in a Rat Model of Subarachnoid Hemorrhage.

Ulinastatin alleviates early brain injury after intracerebral hemorrhage by inhibiting oxidative stress and neuroinflammation via ROS/MAPK/Nrf2 signaling pathway

Efficacy of Simvastatin in the Treatment of Rats with Cerebral Vasospasm after Subarachnoid Hemorrhage

Protective Effects Of Urinary Trypsin Inhibitor On Vascular Permeability Following Subarachnoid Hemorrhage In A Rat Model

A Study on the Protective Effect and Its Mechanism of Ulinastatin in Cerebral Ischemia Reperfusion Injury

Protective Effect and Mechanism of Ulinastatin on Rats with Hemorrhagic Shock

Effects of Ulinastatin, A Urinary Trypsin Inhibitor, on Synaptic Plasticity and Spatial Memory in A Rat Model of Cerebral Ischemia/Reperfusion Injury

Ulinastatin alleviates early brain injury after intracerebral hemorrhage by inhibiting necroptosis and neuroinflammation via MAPK/NF-κB signaling pathway

Protective Effects of Astragaloside IV on Delayed Cerebral Vasospasm in an Experimental Rat Model of Subarachnoid Hemorrhage

Protective Effects of Ulinastatin on Pancreatic Encephalopathy in Rats